Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman

被引:15
作者
Al Za'abi, Mohammed [1 ]
Al Muqbali, Juhina [1 ]
Al-Waili, Khalid [2 ]
机构
[1] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pharmacol & Clin Pharm, Muscat, Oman
[2] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, Muscat, Oman
关键词
Therapeutic drug monitoring; Developing countries; Plasma concentrations; ANTIEPILEPTIC DRUGS; GUIDELINES; SERVICES; DIGOXIN;
D O I
10.1016/j.jsps.2014.11.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate prospectively the appropriateness of indications, sampling time and outcome of TDM requests at a teaching university hospital in Oman. Methods: A prospective cross-sectional study was conducted over a four months period; October 2013-January 2014 at the Sultan Qaboos University Hospital (SQUH), an 855 bed university teaching hospital. Appropriateness criteria for indications and sampling time were defined a priori. The evaluated drug's requests were for carbamazepine, phenytoin, phenobarbital, valproic acid, digoxin, gentamicin, amikacin, vancomycin, tobramycin, theophylline, lithium, and cyclosporine. Results: Of 733 evaluated TDM requisitions, the majority were for antibiotics (75.0%) followed by antiepileptics (10.5%) and cyclosporine (8.9%). Most of the requests had appropriate indication (78.2%), however, only 28.5% had appropriate sampling time. Results were applied by dosage adjustments in 65.8% of requests and some of the inappropriately sampled requests (15.3%) were used as a basis for modifying the dosage regimen. Of all the reported plasma concentrations 42.3%, 41.2%, and 16.5% were within, below and above the reference range, respectively. Conclusion: TDM service is much less than optimal in SQUH. A lot of effort needs to be carried out to improve TDM use in the developing countries as adjusting the doses on results that are based on wrong sampling time might expose patients to toxicity or therapeutic failure. (C) 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 16 条
[1]   A survey of therapeutic drug monitoring services in Malaysia [J].
Ab Rahman, Ab Fatah ;
Abdelrahim, Hisham Elhag Ahmed ;
Ibrahim, Mohamed Izham Mohamed .
SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (01) :19-24
[2]   Utilization Pattern of Vancomycin in a University Teaching Hospital in Oman: Comparison with International Guidelines [J].
Al Za'abi, Mohammed ;
Shafiq, Samreen ;
Al Riyami, Dawood ;
Ali, Badreldin H. .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (01) :117-121
[3]  
Al Za'abi Mohammed, 2013, Int J Pharm Pract, V21, P117, DOI 10.1111/j.2042-7174.2012.00240.x
[4]   Evaluating Appropriateness of Digoxin, Carbamazepine, Valproic Acid, and Phenytoin Usage by Therapeutic Drug Monitoring [J].
Dalaklioglu, S. .
CLINICAL LABORATORY, 2013, 59 (3-4) :325-331
[5]   Whither therapeutic drug monitoring? [J].
Doogue, M. P. ;
Martin, J. H. .
INTERNAL MEDICINE JOURNAL, 2010, 40 (10) :671-672
[6]   Therapeutic drug monitoring for tomorrow [J].
Eliasson, Erik ;
Lindh, Jonatan D. ;
Malmstrom, Rickard E. ;
Beck, Olof ;
Dahl, Marja-Liisa .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 :S25-S32
[7]   Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram [J].
Haji, Elnaz Ostad ;
Mann, Klaus ;
Dragicevic, Aleksandra ;
Mueller, Matthias J. ;
Boland, Katja ;
Rao, Marie-Luise ;
Fric, Miriam ;
Laux, Gerd ;
Hiemke, Christoph .
THERAPEUTIC DRUG MONITORING, 2013, 35 (03) :396-401
[8]  
Kang Ju-Seop, 2009, Korean Journal of Internal Medicine, V24, P1, DOI 10.3904/kjim.2009.24.1.1
[9]   Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy [J].
Mehler-Wex C. ;
Kölch M. ;
Kirchheiner J. ;
Antony G. ;
Fegert J.M. ;
Gerlach M. .
Child and Adolescent Psychiatry and Mental Health, 3 (1)
[10]  
Mordasini MR, 2002, SWISS MED WKLY, V132, P506